Teichomycin

替考拉宁

Report date: 2024/02/23 17:58:42
NME

Base Information

Drug NameTeichomycin
Drug Alias NameTeicoplanin肽可霉素太古霉素Targocid他格适 +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell wall inhibitorsPeptidoglycan inhibitors
TargetsPeptidoglycan
Therapy Area/IndicationsIntervertebral disc diseasePyodermaCystic Fibrosis +[14] 
Global Approved IndicationsPyodermaWound InfectionEmpyema +[8] 
Approved Indications in ChinaGram-Positive Bacterial Infections
Original Approved Country/TerritoryItalyFrance
Original Approved Date1988/01/01
Country/TerritoryItalyFranceMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesGruppo Lepetit SpaSanofi
Inactive CompaniesNeupharma SrlBezmialem Vakif University
Active IndicationsPyodermaWound InfectionEmpyema +[8] 
Inactive IndicationsIntervertebral disc diseaseCystic FibrosisSpondylolisthesis +[6] 

Other Information

ATC CodeJ01XA02
Related LinksWikipediaDrugBankKEGG